Markets · 1 sources covering this

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

MarketWatchCenter·1h ago
This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month
Viking Therapeutics is developing VK2735, a GLP-1/GIP drug that could compete with Eli Lilly’s Zepbound. Its stock is soaring.
Read at MarketWatch →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/625debb72e7ee4179d71d4cd864068e644d45626"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="This GLP-1 drug helped people maintain their weight loss in a clinical trial &#x2014; even for those taking it once a month"></iframe>

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

How 1 sources are covering this

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month

More from Markets

Fed’s Barkin Warns Inflation Pressures Will Take Time to Pass

Want to retire with more money? Leave the country for work early in your career.

Brazil Election: Lula Warns Against Meddling at UN as Trump Looms Over Vote

S&P Trades Near Record Highs as Oil Prices Ease

Reader

Trust & legal

Across the network

How 1 sources are covering this

This GLP-1 drug helped people maintain their weight loss in a clinical trial &#x2014; even for those taking it once a month

More from Markets

Fed’s Barkin Warns Inflation Pressures Will Take Time to Pass

Want to retire with more money? Leave the country for work early in your career.

Brazil Election: Lula Warns Against Meddling at UN as Trump Looms Over Vote

S&P Trades Near Record Highs as Oil Prices Ease

Reader

Trust & legal

Across the network

This GLP-1 drug helped people maintain their weight loss in a clinical trial — even for those taking it once a month